Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Phonpilas Thongpon(Khon Kaen University), Somchai Pinlaor(The University of Texas MD Anderson Cancer Center)
Cited by 18
Related Papers
Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation‐mediated molecular events related to multistep carcinogenesis
|International Journal of Cancer|2010|107
Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line
|International Journal of Oncology|2018|15
Evaluation of a Commercial Enzyme-Linked Immunosorbent Assay Kit and In-House Fasciola gigantica Cysteine Proteinases-Based Enzyme-Linked Immunosorbent Assays for Diagnosis of Human Fascioliasis
|American Journal of Tropical Medicine and Hygiene|2019|7
Curcumin-Loaded Maltodextrin-Based Proniosomes Potentially Effective against Gemcitabine-Resistant Cholangiocarcinoma
|ACS Applied Bio Materials|2025|4